![](/img/cover-not-exists.png)
Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study
Zhang, Shirong, Zhu, Lucheng, Xia, Bing, Chen, Enguo, Zhao, Qiong, Zhang, Xiaochen, Chen, Xueqin, Chen, Xufeng, Ma, ShenglinVolume:
38
Language:
english
Journal:
Cancer Communications
DOI:
10.1186/s40880-018-0303-2
Date:
December, 2018
File:
PDF, 3.02 MB
english, 2018